M D12 (Doxazosin Mesylate 8 mg)

Pill with imprint M D12 is Purple, Round and has been identified as Doxazosin Mesylate 8 mg. It is supplied by Mylan Pharmaceuticals Inc..

Doxazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure; raynaud's syndrome and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Doxazosin 8 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M D12

Doxazosin Mesylate

Imprint:

M D12

Strength:

8 mg

Color:

Purple

Size:

9.00 mm

Shape:

Round

Availability:

Prescription only

Drug Class:

Antiadrenergic agents, peripherally acting

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Mylan Pharmaceuticals Inc.

Inactive Ingredients:

• lactose anhydrous
• silicon dioxide
• magnesium stearate
• microcrystalline cellulose
• sodium lauryl sulfate
• sodium starch glycolate type A potato
• FD&C Blue No. 2
• D&C Red No. 30

Note: Inactive ingredients may vary.

Labelers / Repackagers:

NDC Code	Labeler / Repackager
00378-4028	Mylan Pharmaceuticals Inc.
67544-0273	Prepak Systems Inc. (repackager)

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer